SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:umu-125034"
 

Search: onr:"swepub:oai:DiVA.org:umu-125034" > Skin- and Plasmaaut...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Ramsauer, BerndUmeå universitet,Medicin,Department of Nephrology, Skaraborgs Hospital, 541 58 Skövde, Sweden (author)

Skin- and Plasmaautofluorescence in hemodialysis with glucose-free or glucose-containing dialysate

  • Article/chapterEnglish2017

Publisher, publication year, extent ...

  • 2017-01-05
  • Springer Science and Business Media LLC,2017
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:umu-125034
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-125034URI
  • https://doi.org/10.1186/s12882-016-0418-0DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Background: Haemodialysis (HD) patients suffer from an increased risk of cardiovascular disease (CVD). Skinautofluorescence (SAF) is a strong marker for CVD. SAF indirectly measures tissue advanced glycation end products(AGE) being cumulative metabolites of oxidative stress and cytokine-driven inflammatory reactions. The dialysatesoften contain glucose.Methods: Autofluorescence of skin and plasma (PAF) were measured in patients on HD during standard treatment(ST) with a glucose-containing dialysate (n = 24). After that the patients were switched to a glucose-free dialysate(GFD) for a 2-week period. New measurements were performed on PAF and SAF after 1 week (M1) and 2 weeks(M2) using GFD. Nonparametric paired statistical analyses were performed between each two periods.Results: SAF after HD increased non-significantly by 1.2% while when a GFD was used during HD at M1, a decreaseof SAF by 5.2% (p = 0.002) was found. One week later (M2) the reduction of 1.6% after the HD was not significant(p = 0.33). PAF was significantly reduced during all HD sessions. Free and protein-bound PAF decreased similarlywhether glucose containing or GFD was used. The HD resulted in a reduction of the total PAF of approximately15%, the free compound of 20% and the protein bound of 10%. The protein bound part of PAF correspondedto approximately 56% of the total reduction. The protein bound concentrations after each HD showed thelowest value after 2 weeks using glucose-free dialysate (p < 0.05). The change in SAF could not be related to achange in PAF.Conclusions: When changing to a GFD, SAF was reduced by HD indicating that such measure may hamperthe accumulation and progression of deposits of AGEs to protein in tissue, and thereby also the developmentof CVD. Glucose-free dialysate needs further attention. Protein binding seems firm but not irreversible.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Engels, Gerwin Erik (author)
  • Graaff, Reindert (author)
  • Sikole, Aleksandar (author)
  • Arsov, Stefan (author)
  • Stegmayr, BerndUmeå universitet,Medicin(Swepub:umu)best0006 (author)
  • Umeå universitetMedicin (creator_code:org_t)

Related titles

  • In:BMC Nephrology: Springer Science and Business Media LLC181471-2369

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view